Cilostazol from Japan
Cilostazol is a quinolinone phosphodiesterase III inhibitor used for intermittent claudication in peripheral artery disease. Its nitrogen-heterocyclic structure qualifies under HTS 2933.99.53.00 as cardiovascular drug. Bulk powder for 50/100mg tablet production.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Poor solubility - laser diffraction PSD critical for BE
• Quinolinone photo-degradation risk - amber packaging mandatory
• CYP3A4 inhibitor - include drug interaction dossier